info@buzaevclinic.ru
Frequently Asked Questions, Articles
You are here: / / / National Healthcare – 2023
National Healthcare - 2023

National Healthcare – 2023

/by
Minister of Health of the Russian Federation Mikhail Albertovich Murashko on December 1, 2023, in Moscow at the ceremonial opening of the 2nd National Congress with international participation "National Healthcare - 2023 "
Minister of Health of the Russian Federation Mikhail Albertovich Murashko on December 1, 2023, in Moscow at the solemn opening ceremony of the 2nd National Congress with international participation “National Healthcare – 2023 “

01 December 2023 in Moscow at the VDNH Congress Hall, the grand opening ceremony of the 2nd National Congress with international participation took place “National Healthcare – 2023 “, where the Minister of Health of the Russian Federation Mikhail Albertovich Murashko participated

“Effective treatment methods and dispensary observation have begun to be applied. Currently, as we form the information field, we evaluate which drug therapies and methods of assistance are the most effective “,

noted the Minister of Health in his report

We see our mission in the implementation of new non-invasive effective treatment methods and are happy to be associated with new effective medicine

In addition, in collaboration with the Research Center of Neurology (Academician S.N. Illarioshkin) and Bashkir State Medical University (Professor Sh.M. Safin), we actively conduct research on the results of our work.

Sergey Nikolaevich Illarioshkin at a focused ultrasound procedure at the V.S. Buzaev International Medical Centre®
Sergey Nikolaevich Illarioshkin at a focused ultrasound procedure at the V.S. Buzaev International Medical Centre®

Sergey Nikolaevich Illarioshkin at a focused ultrasound procedure at the V.S. Buzaev International Medical Centre®

Since the opening of our center, we have presented more than fourteen reports with MRgFUS research results, including at 6 international conferences, published 15 research papers, and defended one PhD dissertation.

This is a good confirmation that our center keeps pace with the times and the main objectives in the development of healthcare in Russia.

Presentations:

  1. Golchenko E. A., Karakulova Yu. V., Galimova R. M. Therapy using MRI-guided focused ultrasound for the tremor form of Parkinson’s disease //Neurological Readings in Perm. – 2020. – P. 61-68.
  2. Galimova R. M. One year as a MRgFUS treatment site (20 min) // Focused Ultrasound Non-invasive Neurosurgery Congress 2021 (5 May 2021). Recording of reports on the official website https://funnc.org/2021).
  3. Galimova R. M. et al. Treatment of Movement Disorders in Parkinson’s Disease and Essential Tremor with MRI-guided Focused Ultrasound // VIII Annual Conference of Neurosurgeons of the Northwestern Federal District (September 23–25, 2021), St. Petersburg
  4. Galimova R. M. Opportunities of an International Telemedicine Operating Team in Non-Invasive Neurosurgery // V All-Russian Scientific and Practical Conference “Current Issues of Functional and Ultrasound Diagnostics” (October 29-30, 2021) on-line.
  5. Galimova R. M. et al. Treatment of Movement Disorders in Parkinson’s Disease and Essential Tremor with MRI-guided Focused Ultrasound // IX All-Russian Congress of Neurosurgeons. Moscow, (June 15-18, 2021)
  6. Galimova R. et al. First in history MRgFUS treatment procedures remote start and successful treatment of PD patients due to COVID-19 epidemic // Mov. Disord Society Virtual Congress (17-22 September 2021) https://www.mdsabstracts.org/abstract/first-in-history-MRgFUS- treatment-procedures-remote-start-and-successful-treatment-of-pd-patients-due-to-covid-19-epidemic/
  7. Kachemaeva O., Galimova R. et al. Anxiety and depression in patients with Parkinson’s disease selected for magnetic resonance-guided focused ultrasound thalamotomy // Mov. Disord Society Virtual Congress (17-22 September 2021).
  8. Galimova R. M. MRI-guided focused ultrasound in the treatment of movement disorders: 2-year Russian experience // Neuroforum–2022 and V National Congress on Parkinson’s Disease and Movement Disorders (June 23–24, 2022)
  9. Safin Sh. M., Galimova R. M., Buzaev I. V. et al. Two-year experience of the first center in Russia for neurosurgical treatment of movement disorders with MRI-guided focused ultrasound (Ufa) // Conference of Neurosurgeons of the Volga Federal District (June 30, 2022 – July 1, 2022)
  10. Kachemaeva O., Galimova R. et al. Bilateral Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy in Medication-Resistant Essential Tremor Treatment. // 2022 International Congress of Mov. Disord Society (15 – 18 September 2022). Madrid, Spain
  11. Galimova R. et al. Transcranial magnetic resonance-guided focused ultrasound in Lance-Adams syndrome // 2022 International Congress of Mov. Disord Society. (15 – 18 September 2022). Madrid, Spain
  12. Akhmadeeva G., Khidiyatova I., Gilyazova I., Umutbaev S., Baitimerov A., Kachemaeva O., Galimova R., Magzhanov R. The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease // 2022 International Congress of Mov. Disord Society (15 – 18 September 2022). Madrid, Spain
  13. Galimova R. M. MRI-guided focused ultrasound for movement disorders and other diseases // Third Congress on Functional and Stereotactic Neurosurgery (March 15-17, 2023, Moscow 12:20–12:40) https://www.nsi.ru/news/tretiy-kongress-po-funktsionalnoy-i-stereotaksicheskoy-neyrokhirurgii-15-17-marta-2023-goda/
  14. Galimova R. M. et al. MRI-guided focused ultrasound in the treatment of dystonia symptoms // Neuroforum–2023 (June 22–23, 2023) https://myneurology.ru/neuroforum2023.

Publications:

  1. Therapy of Movement Disorders Using MRI-guided Focused Ultrasound. Recommendations for Neurologists on Patient Selection / R.M. Galimova, S.N. Illarioshkin, I.V. Buzaev, O.V. Kachemaeva // Bulletin of the National Society for the Study of Parkinson’s Disease and Movement Disorders. – 2020. – No. 1. – P. 9-15.
  2. Anxiety and depression in patients with Parkinson’s disease selected for magnetic resonance-guided focused ultrasound thalamotomy / O. Kachemaeva, R. Galimova, D. Krekotin [et al.] // Mov. Disord. – 2021. – Vol. 36, Suppl. 1. https://doi.org/10.1002/mds.28794. WoS, Sc
  3. Treatment of Movement Disorders in Parkinson’s Disease and Essential Tremor with MRI-guideded Focused Ultrasound / R.M. Galimova [and others. ] // Materials IX All-Russian Congress of Neurosurgeons. – M., 2021. – P. 91-92.
  4. First in history MRgFUS treatment procedures remote start and successful treatment of PD patients due to COVID-19 epidemic / R. Galimova [et al.] // Mov. Disord. – 2021. – Vol. 36, Suppl. 1. – P. 542/ https://doi.org/10.1002/mds.28794. WoS, Sc
  5. The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease / G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, A. Baitimerov, O. Kachemaeva, R. Galimova, R. Magzhanov  // Mov. Disord. – 2021. – Vol. 36. – P. S304-S304. WoS, Sc
  6. Serum Biomarkers in Brain Injury / N.R. Mukhamadeeva, O.V. Kachemaeva, I.V. Buzaev, R.M. Galimova [and others. ] // Nervous Diseases. – 2022. – No. 1. – P. 3-11.VAK
  7. The first experience in Russia of treating patients with essential tremor using MRI-guided focused ultrasound / R.M. Galimova, D.I. Nabiullina, S.N. Illarioshkin [and others. ] // Annals of Clinical and Experimental Neurology. – 2022. – Vol. 16, No. 2. – pp. 5–14. Sc, WAC
  8. The First Experience of Performing Thalamotomy Using MRI-guided Focused Ultrasound in Russia / R.M. Galimova, D.I. Nabiullina, S.N. Illarioshkin [and others. ] // Bulletin of the National Society for the Study of Parkinson’s Disease and Movement Disorders. – 2022. – No. 1. – P. 3-8.
  9. Transcranial magnetic resonance-guided focused ultrasound in Lance-Adams syndrome / R. Galimova, YU. Sidorova, G. Akhmadeeva [et al.] // Mov. Disord. – 2022. – Vol. 37 (Suppl. 1). https://doi.org/10.1002/mds.29223. WoS, Sc
  10. Bilateral magnetic resonance imaging-guided focused ultrasound thalamotomy in medication-resistant essential tremor treatment / O. Kachemaeva, R. Galimova, D. Krekotin [et al.] // Mov. Disord. – 2022. – Vol. 37 (Suppl 1). https://doi.org/10.1002/mds.29223. WoS, Sc
  11. COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease / G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, O. Kachemaeva, A. Baitimerov, R. Galimova, R. Magzhanov // Mov. Disord. – 2022. – Vol. 37. – P. S560-S561. WoS, Sc
  12. General Results of 2-Year Application of MRI-guided Focused Ultrasound in the Treatment of Movement Disorders in the Russian Federation / R.M. Galimova, D.I. Nabiullina, S.N. Illarioshkin [and others. ] // Bulletin of the National Society for the Study of Parkinson’s Disease and Movement Disorders. – 2022. – No. 2. – P. 38-42.
  13. 13. Treatment of the Akinetic-Rigid Form of Parkinson’s Disease Complicated by the Development of Fluctuations and Dyskinesias Using the Destruction Method with Focused Ultrasound / G.N. Akhmadeeva, R.M. Galimova, D.I. Nabiullina [and others. ] // Nervous Diseases. -2022. – No. 4. – pp. 26-30.VAK
  14. 14. Experience of Staged and Simultaneous Bilateral Thalamotomy Using MRI-guided Focused Ultrasound in the Treatment of Essential Tremor / D.I. Nabiullina, R.M. Galimova, S.N. Illarioshkin [and others. ] // Journal of Neurology and Psychiatry named after S.S. Korsakov. – 2023. – Vol. 123, No. 7. – pp. 65‑73. Sc, WAC
  15. 15. Reoperation Using MRI-guided Focused Ultrasound in Patients with Essential Tremor / D.I. Nabiullina, R.M. Galimova, Yu.A. Sidorova [and others. ] // Nervous Diseases. – 2023. – No. 2. – pp. 59-63.VAK
  16. 16. Buzaev IV, Galimova RM,Nabiullina DI, Illarioshkin SN, Zagidullin NS,Safin SM. Magnetic resonance imaging‐guidedfocused ultrasound thalamotomy launch withremote telemedicine international proctorship.Chronic Dis Transl Med. 2023;1‐11.doi:10.1002/cdt3.92 https://onlinelibrary.wiley.com/doi/10.1002/cdt3.92